Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Nature Medicine|June 14, 2016
Stimulating the RIG-I pathway to kill cells in the latent HIV reservoir following viral reactivationPeilin Li, Philipp Kaiser, Harry W Lampiris, et al.AIDS (London, England)|April 16, 2024
Differential susceptibility of cells infected with defective and intact HIV proviruses to killing by obatoclax and other small moleculesGayatri Nikhila Kadiyala, Sushama Telwatte, Adam Wedrychowski, et al.Journal of Lipid Research|August 3, 2010
Regulation of ABCG1 expression in human keratinocytes and murine epidermisYan J Jiang, Biao Lu, Elizabeth J Tarling, et al.AIDS (London, England)|September 10, 2020
Mechanistic differences underlying HIV latency in the gut and blood contribute to differential responses to latency-reversing agentsSushama Telwatte, Peggy Kim, Tsui-Hua Chen, et al.The Journal of Biological Chemistry|May 12, 2009
Ceramide stimulates ABCA12 expression via peroxisome proliferator-activated receptor {delta} in human keratinocytesYan J Jiang, Yoshikazu Uchida, Biao Lu, et al.JCI Insight|August 20, 2024
Mechanisms and efficacy of small molecule latency-promoting agents to inhibit HIV reactivation ex vivoJulie Janssens, Peggy Kim, Sun Jin Kim, et al.Retrovirology|November 13, 2019
Heterogeneity in HIV and cellular transcription profiles in cell line models of latent and productive infection: implications for HIV latencySushama Telwatte, Sara Morón-López, Dvir Aran, et al.Plos Pathogens|November 16, 2018
Gut and blood differ in constitutive blocks to HIV transcription, suggesting tissue-specific differences in the mechanisms that govern HIV latencySushama Telwatte, Sulggi Lee, Ma Somsouk, et al.Journal of the International AIDS Society|July 8, 2021
Tissue-specific differences in HIV DNA levels and mechanisms that govern HIV transcription in blood, gut, genital tract and liver in ART-treated womenSara Moron-Lopez, Guorui Xie, Peggy Kim, et al.Proceedings of the National Academy of Sciences of the United States of America|June 24, 2020
HSF1 inhibition attenuates HIV-1 latency reversal mediated by several candidate LRAs In Vitro and Ex VivoAndrew Timmons, Emily Fray, Mithra Kumar, et al.Pageof 3